Hepatoprotective Efficacy of Gene(R) L-Ergothioneine Capsules: A Self-Controlled Clinical Trial
He, R.; Ding, W.; Cao, J.; Ju, H.; Liu, F.; Xiao, G.
Show abstract
ContextErogothioniene (EGT), a potent natural antioxidant, exerts hepatoprotection. However, human clinical evidence remains absent. Objectiveto observe the clinical efficacy and safety studies of GeneIII(R) L-Ergothioneine Capsules in the Hepatoprotective Efficacy. Materials and methodsThirty subjects with some abnormal liver function indicators were selected to take 2 capsules of 30mg GeneIII(R) L-Ergothioneine Capsules per day, for 30 consecutive days. The changes in serum liver function biomarkers, clinical efficacy self-rating scale, and Pittsburgh sleep quality index scale (PSQI) from baseline in different visit cycles were compared by self-control. All adverse events that occured after receiving the trial medication were also tracked and the incidence of adverse events during the trial period was calculated. ResultsAll subjects completed treatment and follow-up. After taking GeneIII(R) L-Ergothioneine Capsules, the subjects aspartate aminotransferase (AST) levels were significantly reduced compared to baseline (p=0.0082). Additionally, alanine aminotransferase (ALT) levels were also significantly reduced (p=0.0025), gamma-glutamyl transferase (GGT) levels were significantly reduced compared to baseline (p=0.0270). Physical function scores on the Clinical Efficacy Self-Assessment Scale improved significantly compared to baseline. Physical function scores decreased significantly by 39.04% compared to baseline (p<0.0001). Additionally, the level of daytime functional impairment on the Pittsburgh Sleep Quality Index was significantly reduced by 51.56% compared to baseline (p=0.0038). No adverse events occurred throughout the study. No side effects were observed clinically, confirming the reliable safety of GeneIII(R) L-Ergothioneine Capsules under the current study design. ConclusionGeneIII(R) L-Ergothioneine Capsules have a significant effect on improving liver function, physical function, and sleep quality in subjects, and the overall safety is good.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Combinatorial effects of Zingiber officinale and Citrus limon juices: Hypolipidemic and antioxidant insights from in vivo, in vitro, and in silico investigations 96%
- Efficacy and safety of Mojeaga remedy in combination with conventional oral iron therapy for correcting anemia in obstetric population: a phase II randomized pilot clinical trial 95%
- Title-Effects of Catha Edulis Forsk on Spatial Cognition and correlation with serum electrolytes in Wild- type Male White Albino Rats 95%
Similar papers in this journal
- Structural variability, expression profile and pharmacogenetics properties of TMPRSS2 gene as a potential target for COVID-19 therapy 92%
- A Comparative Genome-wide Transcriptome Analysis of Glucocorticoid Responder and Non-Responder Primary Human Trabecular Meshwork Cells 91%
- Unveiling sex-based differences in the effects of alcohol abuse: a comprehensive functional meta-analysis of transcriptomic studies 91%
Similar papers in this journal
- Hydroxychloroquine increased psychiatric-like behaviors and disrupted the expression of related genes in the mouse brain 93%
- The mitochondrial deubiquitinase USP30 regulates AKT/mTOR signaling 93%
- Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic scoping review 93%
Similar papers in this journal
- A Randomized, Double-Blind, Placebo Controlled Trial to Assess the Effectiveness and Safety of Melatonin and Three Formulations of Floraworks Proprietary TruCBN™ for Improving Sleep 95%
- Effects of cannabidiol on activated immune-inflammatory pathways in major depressive patients and healthy controls 93%
- Ursolic acid inhibits cell migration and promotes JNK-dependent lysosomal associated cell death in Glioblastoma multiforme cells 92%
Similar papers in this journal
- Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugs 91%
- A Strategy to Treat COVID-19 Disease with Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Non-clinical Pharmacokinetic Study 91%
- Managing Endothelial Dysfunction in COVID-19: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial at the Lebanese American University Medical Center - Rizk Hospital (MEDIC-LAUMCRH) 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.